{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:38:47Z","timestamp":1774366727091,"version":"3.50.1"},"reference-count":169,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.trre.2013.10.001","type":"journal-article","created":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T12:55:23Z","timestamp":1381409723000},"page":"63-75","source":"Crossref","is-referenced-by-count":43,"title":["Blood disorders after kidney transplantation"],"prefix":"10.1016","volume":"28","author":[{"given":"Roman","family":"Reindl-Schwaighofer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Oberbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2013.10.001_bb0005","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1432-2277.2012.01513.x","article-title":"Anemia and erythrocytosis in patients after kidney transplantation","volume":"25","author":"Malyszko","year":"2012","journal-title":"Transplant international: official journal of the European Society for Organ Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0850","doi-asserted-by":"crossref","first-page":"86","DOI":"10.12659\/AOT.883227","article-title":"Anemia in solid organ transplantation","volume":"17","author":"Malyszko","year":"2012","journal-title":"Annals of transplantation: quarterly of the Polish Transplantation Society"},{"key":"10.1016\/j.trre.2013.10.001_bb0015","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2215\/CJN.01190211","article-title":"Posttransplantation anemia: mechanisms and management","volume":"6","author":"Yabu","year":"2011","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11255-009-9558-5","article-title":"Hematologic abnormalities following renal transplantation","volume":"42","author":"Marinella","year":"2010","journal-title":"International urology and nephrology"},{"key":"10.1016\/j.trre.2013.10.001_bb0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/asheducation-2010.1.281","article-title":"Hematologic disorders after solid organ transplantation","volume":"2010","author":"Smith","year":"2010","journal-title":"Hematology\/the Education Program of the American Society of Hematology American Society of Hematology Education Program"},{"key":"10.1016\/j.trre.2013.10.001_bb0030","doi-asserted-by":"crossref","first-page":"b4018","DOI":"10.1136\/bmj.b4018","article-title":"Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study","volume":"339","author":"Heinze","year":"2009","journal-title":"Bmj"},{"key":"10.1016\/j.trre.2013.10.001_bb0035","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1034\/j.1600-6143.2003.00133.x","article-title":"Prevalence and management of anemia in renal transplant recipients: a European survey","volume":"3","author":"Vanrenterghem","year":"2003","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1016\/j.trre.2013.10.001_bb0040","doi-asserted-by":"crossref","first-page":"c127","DOI":"10.1159\/000319660","article-title":"Prevalence and management of anaemia in renal transplant recipients: data from ten European centres","volume":"117","author":"Molnar","year":"2011","journal-title":"Nephron Clinical practice"},{"key":"10.1016\/j.trre.2013.10.001_bb0045","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/TP.0b013e31824b36fa","article-title":"Anemia after kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: a time-varying analysis","volume":"93","author":"Jones","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0050","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1046\/j.1600-6135.2003.00224.x","article-title":"Anemia: a continuing problem following kidney transplantation","volume":"3","author":"Mix","year":"2003","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1016\/j.trre.2013.10.001_bb0855","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/kisup.2012.37","article-title":"KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.trre.2013.10.001_bb0060","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.transproceed.2006.12.036","article-title":"Anemia in the period immediately following renal transplantation","volume":"39","author":"Ourahma","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2013.10.001_bb0065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ki.1987.241","article-title":"Dynamics of erythropoiesis following renal transplantation","volume":"32","author":"Besarab","year":"1987","journal-title":"Kidney international"},{"key":"10.1016\/j.trre.2013.10.001_bb0070","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1432-2277.2011.01340.x","article-title":"Prevalence and determinants of anemia in the immediate postkidney transplant period","volume":"24","author":"Poesen","year":"2011","journal-title":"Transplant international: official journal of the European Society for Organ Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0075","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1432-2277.2008.00814.x","article-title":"Iron deficiency anemia and iron losses after renal transplantation","volume":"22","author":"Zheng","year":"2009","journal-title":"Transplant international: official journal of the European Society for Organ Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJM198907203210304","article-title":"Serum erythropoietin levels after renal transplantation","volume":"321","author":"Sun","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2013.10.001_bb0085","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.1600-6143.2003.00315.x","article-title":"The burden of chronic kidney disease in renal transplant recipients","volume":"4","author":"Karthikeyan","year":"2004","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"Suppl 5","key":"10.1016\/j.trre.2013.10.001_bb0090","doi-asserted-by":"crossref","first-page":"V54","DOI":"10.1093\/ndt\/gfh1057","article-title":"Anaemia after renal transplantation","volume":"19","author":"Vanrenterghem","year":"2004","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association \u2013 European Renal Association"},{"key":"10.1016\/j.trre.2013.10.001_bb0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1053\/j.ajkd.2006.11.034","article-title":"Anemia after kidney transplantation is not completely explained by reduced kidney function","volume":"49","author":"Chadban","year":"2007","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"key":"10.1016\/j.trre.2013.10.001_bb0100","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1681\/ASN.2006010027","article-title":"Posttransplantation anemia at 12months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality","volume":"17","author":"Imoagene-Oyedeji","year":"2006","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0105","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/TP.0b013e31816a8a1f","article-title":"Negative impact of one-year anemia on long-term patient and graft survival in kidney transplant patients receiving calcineurin inhibitors and mycophenolate mofetil","volume":"85","author":"Kamar","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0110","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1093\/ndt\/gfl457","article-title":"A prospective study of anaemia and long-term outcomes in kidney transplant recipients","volume":"21","author":"Winkelmayer","year":"2006","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association \u2013 European Renal Association"},{"key":"10.1016\/j.trre.2013.10.001_bb0115","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1600-6143.2006.01727.x","article-title":"Anemia is associated with mortality in kidney-transplanted patients \u2013 a prospective cohort study","volume":"7","author":"Molnar","year":"2007","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1016\/j.trre.2013.10.001_bb0120","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1093\/ndt\/gfh256","article-title":"Anaemia is common after kidney transplantation, especially among African Americans","volume":"19","author":"Shibagaki","year":"2004","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association \u2013 European Renal Association"},{"key":"10.1016\/j.trre.2013.10.001_bb0125","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1681\/ASN.V133794","article-title":"Anemia and iron deficiencies among long-term renal transplant recipients","volume":"13","author":"Lorenz","year":"2002","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0130","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.transproceed.2004.11.081","article-title":"Iron deficiency \u2013 an underrecognized problem in nonanemic and erythrocytic kidney transplant recipients: risks and effects of ACEI and of iron treatment","volume":"37","author":"Jimeno","year":"2005","journal-title":"Transplantation proceedings"},{"key":"10.1016\/j.trre.2013.10.001_bb0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/504812","article-title":"Parvovirus B19 infection after transplantation: a review of 98 cases","volume":"43","author":"Eid","year":"2006","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.trre.2013.10.001_bb0140","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1034\/j.1399-0012.2000.140612.x","article-title":"Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature","volume":"14","author":"Geetha","year":"2000","journal-title":"Clinical transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0145","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.TP.0000092957.49621.37","article-title":"Parvovirus B19 infection-associated red-cell aplasia in renal-transplant recipients: clues from the bone marrow","volume":"77","author":"Garewal","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/00222615-25-2-151","article-title":"The prevalence of antibody to human parvovirus B19 in England and Wales","volume":"25","author":"Cohen","year":"1988","journal-title":"J Med Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.trre.2013.10.001_bb0155","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.2215\/CJN.01060307","article-title":"Parvovirus B19 and the kidney","volume":"2","author":"Waldman","year":"2007","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/medicina48060044","article-title":"Anemia as a complication of parvovirus b19 infection in renal transplant recipients","volume":"48","author":"Capenko","year":"2012","journal-title":"Medicina"},{"key":"10.1016\/j.trre.2013.10.001_bb0165","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/cid\/cis1046","article-title":"Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature","volume":"56","author":"Crabol","year":"2013","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.trre.2013.10.001_bb0170","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMra030840","article-title":"Parvovirus B19","volume":"350","author":"Young","year":"2004","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.trre.2013.10.001_bb0175","doi-asserted-by":"crossref","first-page":"E64","DOI":"10.1111\/j.1399-3062.2012.00773.x","article-title":"How many times can parvovirus B19-related anemia recur in solid organ transplant recipients?","volume":"14","author":"Gosset","year":"2012","journal-title":"Transplant infectious disease: an official journal of the Transplantation Society"},{"key":"10.1016\/j.trre.2013.10.001_bb0180","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/ndt\/17.10.1840","article-title":"Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy","volume":"17","author":"Liefeldt","year":"2002","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"10.1016\/j.trre.2013.10.001_bb0185","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/01.tp.0000205174.97275.b5","article-title":"Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors","volume":"81","author":"Shah","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0190","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/01.ASN.0000125551.59739.2E","article-title":"Pharmacoepidemiology of anemia in kidney transplant recipients","volume":"15","author":"Winkelmayer","year":"2004","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0195","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.transproceed.2006.06.043","article-title":"Effects of azathioprine and mycophenolate mofetil-immunosuppressive regimens on the erythropoietic system of renal transplant recipients","volume":"38","author":"Khosroshahi","year":"2006","journal-title":"Transplantation proceedings"},{"key":"10.1016\/j.trre.2013.10.001_bb0860","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/ndt\/12.3.628a","article-title":"Azathioprine induced macrocytosis and red cell aplasia in renal transplant patients","volume":"12","author":"Zazgornik","year":"1997","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"10.1016\/j.trre.2013.10.001_bb0205","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.clinthera.2008.04.014","article-title":"Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients","volume":"30","author":"Kuypers","year":"2008","journal-title":"Clinical therapeutics"},{"key":"10.1016\/j.trre.2013.10.001_bb0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/TP.0b013e318200e971","article-title":"Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation","volume":"91","author":"Jacobson","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0215","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1111\/j.1600-6143.2004.00612.x","article-title":"Comparative effects of sirolimus and mycophenolate mofetil on erythropoiesis in kidney transplant patients","volume":"4","author":"Augustine","year":"2004","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1016\/j.trre.2013.10.001_bb0220","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1432-2277.2007.00506.x","article-title":"Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function","volume":"20","author":"Friend","year":"2007","journal-title":"Transplant international: official journal of the European Society for Organ Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0225","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ki.2009.231","article-title":"Posttransplant anemia: the role of sirolimus","volume":"76","author":"Fishbane","year":"2009","journal-title":"Kidney international"},{"key":"10.1016\/j.trre.2013.10.001_bb0230","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.tp.0000219703.39149.85","article-title":"Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials","volume":"81","author":"Webster","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1432-2277.2005.00190.x","article-title":"Marked erythrocyte microcytosis under primary immunosuppression with sirolimus","volume":"19","author":"Kim","year":"2006","journal-title":"Transplant international: official journal of the European Society for Organ Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0240","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/TP.0b013e3181814a96","article-title":"Reduction in erythropoietin resistance after conversion from sirolimus to enteric coated mycophenolate sodium","volume":"86","author":"Augustine","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0245","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/01.tp.0000179106.07382.6a","article-title":"Anemia after late introduction of sirolimus may correlate with biochemical evidence of a chronic inflammatory state","volume":"80","author":"Thaunat","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0250","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/ndt\/gfp674","article-title":"Anaemia, microcytosis and sirolimus \u2013 is iron the missing link?","volume":"25","author":"Sofroniadou","year":"2010","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association \u2013 European Renal Association."},{"key":"10.1016\/j.trre.2013.10.001_bb0255","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.transproceed.2007.06.032","article-title":"Study of anemia after late introduction of everolimus in the immunosuppressive treatment of renal transplant patients","volume":"39","author":"Sanchez Fructuoso","year":"2007","journal-title":"Transplantation proceedings"},{"key":"10.1016\/j.trre.2013.10.001_bb0260","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5414\/CN107036","article-title":"Tacrolimus-induced thrombotic microangiopathy: natural history of a severe, acute vasculopathy","volume":"77","author":"Carson","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.trre.2013.10.001_bb0265","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3324\/haematol.10733","article-title":"Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients","volume":"92","author":"Elimelakh","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.trre.2013.10.001_bb0270","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2215\/CJN.01841105","article-title":"Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation","volume":"1","author":"Ruggenenti","year":"2006","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0275","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1016\/j.trre.2013.10.001_bb0280","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/1568026043451311","article-title":"Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers","volume":"4","author":"Marathias","year":"2004","journal-title":"Current topics in medicinal chemistry"},{"key":"10.1016\/j.trre.2013.10.001_bb0285","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.healun.2008.07.025","article-title":"Dapsone-induced hemolytic anemia in lung allograft recipients","volume":"27","author":"Naik","year":"2008","journal-title":"The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation"},{"issue":"Suppl 1","key":"10.1016\/j.trre.2013.10.001_bb0290","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ndt\/17.suppl_1.41","article-title":"Role of anaemia in cardiovascular mortality and morbidity in transplant patients","volume":"17","author":"Ponticelli","year":"2002","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"10.1016\/j.trre.2013.10.001_bb0295","first-page":"176","article-title":"Cardiovascular disease after renal transplantation","volume":"20","author":"Kasiske","year":"2000","journal-title":"Seminars in nephrology"},{"key":"10.1016\/j.trre.2013.10.001_bb0300","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.ASN.0000043141.67989.39","article-title":"Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia","volume":"14","author":"Rigatto","year":"2003","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0305","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1681\/ASN.V1341084","article-title":"Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease","volume":"13","author":"Rigatto","year":"2002","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0310","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.TP.0000084872.26360.C5","article-title":"Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients","volume":"76","author":"Djamali","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0315","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/sj.ki.5000105","article-title":"Association of anemia with outcomes in men with moderate and severe chronic kidney disease","volume":"69","author":"Kovesdy","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2013.10.001_bb0320","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1681\/ASN.V1061309","article-title":"Hematocrit levels and hospitalization risks in hemodialysis patients","volume":"10","author":"Xia","year":"1999","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0325","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1016\/j.transproceed.2009.07.090","article-title":"Anemia and erythrocytosis after kidney transplantation: a 5-year graft function and survival analysis","volume":"41","author":"Kolonko","year":"2009","journal-title":"Transplantation proceedings"},{"key":"10.1016\/j.trre.2013.10.001_bb0330","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.2215\/CJN.04641007","article-title":"Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection","volume":"3","author":"Chhabra","year":"2008","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0335","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1016\/j.transproceed.2008.07.139","article-title":"Anemia after renal transplantation: an underestimated problem","volume":"40","author":"Ott","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2013.10.001_bb0340","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/TP.0b013e318160254f","article-title":"Risk factors for cardiovascular events after successful renal transplantation","volume":"85","author":"Vanrenterghem","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0345","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10157-009-0171-9","article-title":"Does posttransplant anemia at 6months affect long-term outcome of live-donor kidney transplantation? A single-center experience","volume":"13","author":"Gheith","year":"2009","journal-title":"Clinical and experimental nephrology"},{"key":"10.1016\/j.trre.2013.10.001_bb0350","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/TP.0b013e318181e276","article-title":"The impact of hemoglobin levels on patient and graft survival in renal transplant recipients","volume":"86","author":"Moore","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0355","doi-asserted-by":"crossref","first-page":"c7","DOI":"10.1159\/000105138","article-title":"Chronic kidney disease management: comparison between renal transplant recipients and nontransplant patients with chronic kidney disease","volume":"107","author":"Akbari","year":"2007","journal-title":"Nephron Clinical practice"},{"key":"10.1016\/j.trre.2013.10.001_bb0360","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1399-0012.2011.01545.x","article-title":"Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysis","volume":"26","author":"Kamar","year":"2012","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2013.10.001_bb0365","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.trre.2013.10.001_bb0370","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Drueke","year":"2006","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.trre.2013.10.001_bb0375","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.trre.2013.10.001_bb0380","first-page":"11","article-title":"Cardio-renal anemia syndrome","volume":"12","author":"Efstratiadis","year":"2008","journal-title":"Hippokratia"},{"key":"10.1016\/j.trre.2013.10.001_bb0385","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/TP.0b013e318248375a","article-title":"A randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation","volume":"93","author":"Mudge","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0390","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.trre.2013.10.001_bb0395","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/j.ajkd.2008.05.029","article-title":"Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis","volume":"52","author":"Streja","year":"2008","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"issue":"6","key":"10.1016\/j.trre.2013.10.001_bb0865","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gft033","article-title":"Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement","volume":"28","author":"Locatelli","year":"2013","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2013.10.001_bb0405","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1681\/ASN.2005090997","article-title":"Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients","volume":"17","author":"Regidor","year":"2006","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0410","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1056\/NEJMoa1005109","article-title":"Erythropoietic response and outcomes in kidney disease and type 2 diabetes","volume":"363","author":"Solomon","year":"2010","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.trre.2013.10.001_bb0415","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ki.2008.295","article-title":"Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes","volume":"74","author":"Szczech","year":"2008","journal-title":"Kidney international"},{"key":"10.1016\/j.trre.2013.10.001_bb0420","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1399-0012.2012.01598.x","article-title":"Associations of pre-transplant anemia management with post-transplant delayed graft function in kidney transplant recipients","volume":"26","author":"Molnar","year":"2012","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2013.10.001_bb0425","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2215\/CJN.00380111","article-title":"Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease","volume":"6","author":"Wagner","year":"2011","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0430","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.2215\/CJN.05590611","article-title":"Serum erythropoietin level and mortality in kidney transplant recipients","volume":"6","author":"Molnar","year":"2011","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0435","first-page":"270","article-title":"Increased erythropoietin requirements in patients with failed renal transplants returning to a dialysis programme","volume":"9","author":"Almond","year":"1994","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association \u2013 European Renal Association"},{"key":"10.1016\/j.trre.2013.10.001_bb0440","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.ajkd.2012.07.014","article-title":"Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis","volume":"61","author":"Koulouridis","year":"2013","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"key":"10.1016\/j.trre.2013.10.001_bb0445","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/j.ajkd.2009.05.010","article-title":"Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations","volume":"54","author":"Bradbury","year":"2009","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"key":"10.1016\/j.trre.2013.10.001_bb0450","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1681\/ASN.2011060546","article-title":"Correction of postkidney transplant anemia reduces progression of allograft nephropathy","volume":"23","author":"Choukroun","year":"2012","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0455","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/j.1600-6143.2010.03142.x","article-title":"High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study","volume":"10","author":"Martinez","year":"2010","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"5","key":"10.1016\/j.trre.2013.10.001_bb0870","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/ndt\/gfs575","article-title":"How important is transfusion avoidance in 2013?","volume":"28","author":"Macdougall","year":"2013","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2013.10.001_bb0465","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1399-0012.2008.00947.x","article-title":"Post-transplant erythrocytosis: a disappearing phenomenon?","volume":"23","author":"Kiberd","year":"2009","journal-title":"Clinical transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0470","first-page":"83","article-title":"Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study","volume":"45","author":"Kessler","year":"1996","journal-title":"Clinical nephrology"},{"key":"10.1016\/j.trre.2013.10.001_bb0475","first-page":"29","article-title":"Erythropoietin production after kidney transplantation","volume":"1","author":"Gaciong","year":"1996","journal-title":"Annals of transplantation: quarterly of the Polish Transplantation Society"},{"key":"10.1016\/j.trre.2013.10.001_bb0480","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1523-1755.2003.00850.x","article-title":"Posttransplant erythrocytosis","volume":"63","author":"Vlahakos","year":"2003","journal-title":"Kidney international"},{"key":"10.1016\/j.trre.2013.10.001_bb0485","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00007890-199810270-00015","article-title":"Erythrocytosis after renal transplantation represents an abnormality of insulin-like growth factor-I and its binding proteins","volume":"66","author":"Brox","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0490","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1525-1594.2009.00823.x","article-title":"Serum stem cell factor level in renal transplant recipients with posttransplant erythrocytosis","volume":"33","author":"Kiykim","year":"2009","journal-title":"Artificial organs"},{"key":"10.1016\/j.trre.2013.10.001_bb0495","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ki.1983.86","article-title":"Postrenal transplant erythrocytosis: a review of 53 patients","volume":"23","author":"Wickre","year":"1983","journal-title":"Kidney international"},{"issue":"8 Suppl","key":"10.1016\/j.trre.2013.10.001_bb0500","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.tp.0000260765.41275.e2","article-title":"A report of the Lisbon Conference on the care of the kidney transplant recipient","volume":"83","author":"Abbud-Filho","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0505","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","article-title":"Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence","volume":"7","author":"Hiremath","year":"2007","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1016\/j.trre.2013.10.001_bb0510","first-page":"241","article-title":"Therapeutic efficiency of phlebotomy in posttransplant hypertension associated with erythrocytosis","volume":"40","author":"Barenbrock","year":"1993","journal-title":"Clinical nephrology"},{"key":"10.1016\/j.trre.2013.10.001_bb0515","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199007123230203","article-title":"Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation","volume":"323","author":"Bakris","year":"1990","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.trre.2013.10.001_bb0520","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1600-6143.2009.02699.x","article-title":"Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study","volume":"9","author":"Zafrani","year":"2009","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1016\/j.trre.2013.10.001_bb0525","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1523-1755.2000.00816.x","article-title":"Long-term survival in renal transplant recipients with graft function","volume":"57","author":"Ojo","year":"2000","journal-title":"Kidney international"},{"key":"10.1016\/j.trre.2013.10.001_bb0530","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.transproceed.2004.03.016","article-title":"Hematologic toxicity of immunosuppressive treatment","volume":"36","author":"Danesi","year":"2004","journal-title":"Transplantation proceedings"},{"key":"10.1016\/j.trre.2013.10.001_bb0875","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0540","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/ndt\/gfl539","article-title":"Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients","volume":"22","author":"Rerolle","year":"2007","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association \u2013 European Renal Association"},{"key":"10.1016\/j.trre.2013.10.001_bb0545","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1034\/j.1399-0012.2003.00052.x","article-title":"A neutropenia suggesting an interaction between valacyclovir and mycophenolate mofetil","volume":"17","author":"Royer","year":"2003","journal-title":"Clinical transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0550","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/01.tp.0000257923.69422.4d","article-title":"Leukopenia complicates cytomegalovirus prevention after renal transplantation with alemtuzumab induction","volume":"83","author":"Walker","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0555","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00007691-199902000-00006","article-title":"Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation","volume":"21","author":"Zucker","year":"1999","journal-title":"Therapeutic drug monitoring"},{"key":"10.1016\/j.trre.2013.10.001_bb0560","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/01.ASN.0000079616.71891.F5","article-title":"Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation","volume":"14","author":"Knoll","year":"2003","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0565","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1034\/j.1399-0012.2003.00026.x","article-title":"The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation","volume":"17","author":"Pelletier","year":"2003","journal-title":"Clinical transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0570","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.tp.0000225830.76907.d0","article-title":"Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients","volume":"82","author":"Diaz-Pedroche","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0575","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1399-0012.2003.00102.x","article-title":"French Thymoglobuline Pharmacovigilance Study G. Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy","volume":"17","author":"Buchler","year":"2003","journal-title":"Clinical transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0580","doi-asserted-by":"crossref","first-page":"E184","DOI":"10.1111\/j.1399-0012.2012.01624.x","article-title":"Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation","volume":"26","author":"Gabardi","year":"2012","journal-title":"Clinical transplantation"},{"issue":"Suppl. 3","key":"10.1016\/j.trre.2013.10.001_bb0880","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipient","volume":"9","year":"2009","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1016\/j.trre.2013.10.001_bb0590","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1016\/j.transproceed.2005.07.051","article-title":"Signs and symptoms of cytomegalovirus disease in kidney transplant recipients","volume":"37","author":"Pour-Reza-Gholi","year":"2005","journal-title":"Transplantation proceedings"},{"key":"10.1016\/j.trre.2013.10.001_bb0595","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/01.TP.0000128834.48158.9E","article-title":"Cytomegalovirus-induced pancytopenia after heart transplantation","volume":"78","author":"Fuchs","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0600","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.transproceed.2007.02.014","article-title":"Clinical manifestation, laboratory findings, and the response of treatment in kidney transplant recipients with CMV infection","volume":"39","author":"Razeghi","year":"2007","journal-title":"Transplantation proceedings"},{"key":"10.1016\/j.trre.2013.10.001_bb0605","first-page":"CD003774","article-title":"Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients","volume":"2","author":"Hodson","year":"2013","journal-title":"Cochrane database of systematic reviews"},{"key":"10.1016\/j.trre.2013.10.001_bb0610","first-page":"CD005133","article-title":"Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients","volume":"2","author":"Owers","year":"2013","journal-title":"Cochrane database of systematic reviews"},{"key":"10.1016\/j.trre.2013.10.001_bb0615","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2006.00618.x","article-title":"Cytomegalovirus in transplantation \u2013 challenging the status quo","volume":"21","author":"Fishman","year":"2007","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2013.10.001_bb0620","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/TP.0b013e3182708e56","article-title":"Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? a systematic review and meta-analysis","volume":"94","author":"Andrassy","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0625","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200011093431905","article-title":"Bone marrow failure associated with human herpesvirus 8 infection after transplantation","volume":"343","author":"Luppi","year":"2000","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.trre.2013.10.001_bb0630","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1432-2277.2012.01443.x","article-title":"Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: review","volume":"25","author":"Lautenschlager","year":"2012","journal-title":"Transplant international: official journal of the European Society for Organ Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0635","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.trre.2013.10.001_bb0640","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1399-0012.2008.00893.x","article-title":"Management of leukopenia in kidney and pancreas transplant recipients","volume":"22","author":"Hartmann","year":"2008","journal-title":"Clinical transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0645","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/TP.0b013e31821c1e70","article-title":"Poor outcomes associated with neutropenia after kidney transplantation: analysis of United States Renal Data System","volume":"92","author":"Hurst","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0650","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10157-010-0323-y","article-title":"Mycophenolate mofetil-induced agranulocytosis in a renal transplant recipient","volume":"14","author":"Matsui","year":"2010","journal-title":"Clinical and experimental nephrology"},{"key":"10.1016\/j.trre.2013.10.001_bb0655","first-page":"2166","article-title":"Worsening of renal function in a renal transplant patient treated with granulocyte colony-stimulating factor","volume":"10","author":"Minguez","year":"1995","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"10.1016\/j.trre.2013.10.001_bb0660","doi-asserted-by":"crossref","first-page":"E450","DOI":"10.1111\/ctr.12021","article-title":"The role of Thymoglobulin induction in kidney transplantation: an update","volume":"26","author":"Mourad","year":"2012","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2013.10.001_bb0665","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5414\/CNP64103","article-title":"Cardiovascular risk factors in severe chronic renal failure: the role of dietary treatment","volume":"64","author":"Bergesio","year":"2005","journal-title":"Clinical nephrology"},{"key":"10.1016\/j.trre.2013.10.001_bb0670","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Thymoglobulin Induction Study G. Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"Brennan","year":"2006","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.trre.2013.10.001_bb0675","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/01.ASN.0000113248.59077.76","article-title":"Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal","volume":"15","author":"Kreis","year":"2004","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0680","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2001.19.5.1519","article-title":"Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology","volume":"19","author":"Schiffer","year":"2001","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.trre.2013.10.001_bb0685","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"10","author":"Noris","year":"2010","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1016\/j.trre.2013.10.001_bb0690","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrneph.2010.155","article-title":"New insights into postrenal transplant hemolytic uremic syndrome","volume":"7","author":"Zuber","year":"2011","journal-title":"Nature reviews Nephrology"},{"key":"10.1016\/j.trre.2013.10.001_bb0695","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2215\/CJN.00050505","article-title":"Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background","volume":"1","author":"Bresin","year":"2006","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0700","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/00007890-199805270-00023","article-title":"Recurrence of hemolytic-uremic syndrome in renal transplant recipients: a meta-analysis","volume":"65","author":"Ducloux","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0705","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00005792-200003000-00003","article-title":"Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Cooperatif de l'Ile-de-France (GCIF)","volume":"79","author":"Lahlou","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.trre.2013.10.001_bb0710","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.2215\/CJN.10181110","article-title":"Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome","volume":"6","author":"Nester","year":"2011","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0715","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMc1001060","article-title":"Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome","volume":"362","author":"Zimmerhackl","year":"2010","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.trre.2013.10.001_bb0720","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/ajt.12319","article-title":"Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes","volume":"13","author":"Canaud","year":"2013","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1016\/j.trre.2013.10.001_bb0725","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1053\/ajkd.2000.17690","article-title":"Cyclosporine and tacrolimus-associated thrombotic microangiopathy","volume":"36","author":"Pham","year":"2000","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"key":"10.1016\/j.trre.2013.10.001_bb0730","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1111\/j.1600-6143.2005.01047.x","article-title":"Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys","volume":"5","author":"Sartelet","year":"2005","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1016\/j.trre.2013.10.001_bb0735","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/00002018-200124070-00002","article-title":"Drug-induced thrombotic microangiopathy: incidence, prevention and management","volume":"24","author":"Pisoni","year":"2001","journal-title":"Drug safety: an international journal of medical toxicology and drug experience"},{"key":"10.1016\/j.trre.2013.10.001_bb0740","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2165\/00003495-200059040-00013","article-title":"Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections","volume":"59","author":"Ormrod","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.trre.2013.10.001_bb0745","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1681\/ASN.V1161132","article-title":"Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation","volume":"11","author":"Murer","year":"2000","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.trre.2013.10.001_bb0750","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1432-2277.2006.00354.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"19","author":"Ponticelli","year":"2006","journal-title":"Transplant international: official journal of the European Society for Organ Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0755","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ajkd.2003.07.008","article-title":"Thrombotic microangiopathy after renal transplantation in the United States","volume":"42","author":"Reynolds","year":"2003","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"key":"10.1016\/j.trre.2013.10.001_bb0760","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.transproceed.2011.02.064","article-title":"Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation\u2013a case report","volume":"43","author":"Chandran","year":"2011","journal-title":"Transplantation proceedings"},{"key":"10.1016\/j.trre.2013.10.001_bb0765","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.transproceed.2005.02.112","article-title":"Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy","volume":"37","author":"Bren","year":"2005","journal-title":"Transplantation proceedings"},{"key":"10.1016\/j.trre.2013.10.001_bb0770","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1600-6143.2008.02482.x","article-title":"Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombotic microangiopathy","volume":"9","author":"Ashman","year":"2009","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1016\/j.trre.2013.10.001_bb0775","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1517\/14712598.2010.514901","article-title":"Biological agents in kidney transplantation: belatacept is entering the field","volume":"10","author":"Weclawiak","year":"2010","journal-title":"Expert opinion on biological therapy"},{"key":"10.1016\/j.trre.2013.10.001_bb0780","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1182\/blood-2009-07-143545","article-title":"How I, treat EBV lymphoproliferation","volume":"114","author":"Heslop","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.trre.2013.10.001_bb0785","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pcl.2010.01.011","article-title":"Posttransplant lymphoproliferative diseases","volume":"57","author":"Gross","year":"2010","journal-title":"Pediatric clinics of North America"},{"key":"10.1016\/j.trre.2013.10.001_bb0790","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2141.2010.08160.x","article-title":"Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines","volume":"149","author":"Parker","year":"2010","journal-title":"British journal of haematology"},{"key":"10.1016\/j.trre.2013.10.001_bb0795","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.semdp.2012.08.005","article-title":"Immunosuppressive and immunomodulatory therapy-associated lymphoproliferative disorders","volume":"30","author":"Bagg","year":"2013","journal-title":"Seminars in diagnostic pathology"},{"key":"10.1016\/j.trre.2013.10.001_bb0800","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2165\/11635690-000000000-00000","article-title":"Managing post-transplant lymphoproliferative disorders in solid-organ transplant recipients: a review of immunosuppressant regimens","volume":"72","author":"Murukesan","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.trre.2013.10.001_bb0805","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nrclinonc.2012.111","article-title":"T-cell therapy in the treatment of post-transplant lymphoproliferative disease","volume":"9","author":"Bollard","year":"2012","journal-title":"Nature reviews Clinical oncology"},{"key":"10.1016\/j.trre.2013.10.001_bb0810","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.seminhematol.2005.05.017","article-title":"Immune hemolysis associated with transplantation","volume":"42","author":"Petz","year":"2005","journal-title":"Seminars in hematology"},{"key":"10.1016\/j.trre.2013.10.001_bb0815","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1537-2995.2002.00026.x","article-title":"Posttransplant immune-mediated hemolysis","volume":"42","author":"Sokol","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.trre.2013.10.001_bb0820","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1537-2995.1989.29589284137.x","article-title":"Red cell antibody problems in 1000 liver transplants","volume":"29","author":"Ramsey","year":"1989","journal-title":"Transfusion"},{"key":"10.1016\/j.trre.2013.10.001_bb0825","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/j.1537-2995.2011.03192.x","article-title":"Hemolytic anemia after kidney transplantation: a prospective analysis","volume":"51","author":"Achkar","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.trre.2013.10.001_bb0830","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.TP.0000107285.86939.37","article-title":"Groupe Cooperatif de transplantation d'Ile de F. Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature","volume":"77","author":"Karras","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0885","first-page":"429","article-title":"Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem?","volume":"2","author":"Yorgin","year":"2002"},{"key":"10.1016\/j.trre.2013.10.001_bb0840","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1399-0012.2005.00428.x","article-title":"Anemia in kidney transplanted patients","volume":"19","author":"Molnar","year":"2005","journal-title":"Clinical transplantation"},{"key":"10.1016\/j.trre.2013.10.001_bb0845","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1016\/j.transproceed.2005.10.054","article-title":"Prevalence of anemia in renal transplant patients: results from MOST, an observational trial","volume":"37","author":"Fernandez Fresnedo","year":"2005","journal-title":"Transplantation proceedings"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X13001080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X13001080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T18:04:22Z","timestamp":1646762662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X13001080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":169,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0955470X13001080"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2013.10.001","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}